Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats

European Journal of Clinical Investigation

Volumn 40, Issue 11, 2010, Pages 1002-1010

  Chang, Kuo Chu ^a   Tseng, Chuen Den ^b   Lu, Shao Chun ^a   Liang, Jin Tung ^b   Wu, Ming Shiou ^b   Tsai, Ming Shian ^c   Hsu, Kwan Lih ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

Acetyl L carnitine; Aortic input impedance; Free fatty acids; Malondialdehyde; Oxfenicine; Streptozotocin diabetic rats

Indexed keywords

FATTY ACID; GLUCOSE; LEVACECARNINE; MALONALDEHYDE; OXFENICINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTERIAL STIFFNESS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SYSTOLE; VASCULAR RESISTANCE;

ACETYLCARNITINE; ANALYSIS OF VARIANCE; ANIMALS; AORTA; CARNITINE O-PALMITOYLTRANSFERASE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; MALE; RATS; RATS, WISTAR; VITAMIN B COMPLEX;

EID: 78649425898     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02358.x     Document Type: Article

References (45)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(Suppl 5):S1-85.
2. Avogaro A, De Kreutzenberg SV, Negut C, Tiengo A, Scognamiglio R. Diabetic cardiomyopathy: a metabolic perspective. Am J Cardiol 2004;93:A13-6.
3. Ding A, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006;291:H1489-506.
4. Vitale C, Collins P. Optimization of cardiac metabolism in diabetes mellitus. Curr Pharm Des 2008;14:2537-50.
5. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997;34:25-33.
6. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 2002;105:1861-70.
7. Lee L, Horowitz J, Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 2004;25:634-41.
8. Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004;25:455-73.
9. Marciani P, Lindi C, Marzo A, Arrigoni Martelli E, Cardace G, Esposito G. L-carnitine and carnitine ester transport in the rat small intestine. Pharmacol Res 1991;23:157-62.
10. Liu J, Head E, Kuratsune H, Cotman CW, Ames BN. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann NY Acad Sci 2004;1033:117-31.
11. Rupp H, Zarain-Herzberg A, Maisch B. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz 2002;27:621-36.
12. Stephens TW, Higgins AJ, Cook GA, Harris RA. Two mechanisms ptoduce tissue-specific inhibition of fatty acid oxidation by oxfenicine. Biochem J 1985;227:651-60.
13. Vik-Mo H, Mjos OD, Neely JR, Maroko PR, Ribeiro LG. Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardium. Am Heart J 1986;111:1048-54.
14. Dichtl W, Nilsson L, Goncalves I, Ares MP, Banfi C, Calara F et al. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res 1999;84:1085-94.
15. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939-45.
16. Staiger K, Staiger H, Weigert C, Haas C, Haring HU, Kellerer M. Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation. Diabetes 2006;55:3121-6.
17. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100:1230-9.
18. De Kreutzenberg SV, Crepaldi C, Marchetto S, Calò L, Tiengo A, Del Prato S et al. Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition. J Clin Endocrinol Metab 2000;85:793-8.
19. Dimmeler S, Haendeler J, Zeiher AM. Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 2002;13:531-6.
20. Oram JF, Bornfeldt KE. Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes. Front Biosci 2004;9:1240-53.
21. Slatter DA, Paul RG, Murray M, Bailey AJ. Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 1999;274:19661-9.
22. Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000;43:550-7.
23. Milnor WR. Hemodynamics. Baltimore: Williams & Wilkins Co., 1989.
24. Chang KC, Hsu KL, Tseng YZ. Effects of diabetes and gender on mechanical properties of the arterial system in rats: aortic impedance analysis. Exp Biol Med 2003;228:70-8.
25. Nichols WW, O'Rourke MF. McDonald's blood flow in arteries. London: Arnold, 2005.
26. Mitchell GF, Pfeffer MA, Westerhof N, Pfeffer JM. Measurement of aortic input impedance in rats. Am J Physiol 1994;267 (Heart Circ Physiol 36):H1907-15.
27. Liu A, Brin KP, Yin FCP. Estimation of total arterial compliance: An improved method and evaluation of current methods. Am J Physiol 1986; 251 (Heart Circ Physiol 20):H588-600.
28. Laxminarayan S, Sipkema P, Westerhof N. Characterization of the arterial system in the time domain. IEEE Trans Biomed Eng 1978;25:177-84.
29. Westerhof N, Sipkema P, Vanden Bos GC, Elzinga G. Forward and backward waves in the arterial system. Cardiovasc Res 1972;6:648-56.
30. Okabe H, Uji Y, Nagashima K, Noma A. Enzymic determination of free fatty acids in serum. Clin Chem 1980;26:1540-3.
31. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovas Dis 2005;15:316-28.
32. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007;380:50-8.
33. Beuge JA, Aust SD. Microsomal lipids peroxidation. Methods Enzymol 1978;52:302-10.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
35. Roduit R, Nolan C, Alarcon C, Moore P, Barbeau A, Delghingaro-Augusto V et al. A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 2004;53:1007-19.
36. Rask-Madsen C, King GL. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 2005;25:487-96.
37. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006;98:596-606.
38. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 2007;100:769-81.
39. Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 2006;116:1071-80.
40. Shanmugam N, Figarola JL, Li Y, Swiderski PM, Rahbar S, Natarajan R. Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 2008;57:879-88.
41. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-25.
42. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007;211:157-72.
43. O'Rourke MF, Avolio AP, Nichols WW. Left ventricular-systemic arterial coupling in humans and strategies to improve coupling in disease states. In: Yin FCP, editor. Ventricular/Vascular Coupling. New York: Springer-Verlag, 1987:pp 1-19.
44. Okere IC, Chandler MP, McElfresh TA, Rennison JH, Kung TA, Hoit BD et al. Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet. Clin Exp Pharmacol Physiol 2007;34:113-9.
45. Cox RH. Three-dimensional mechanics of arterial segments in vitro methods. J Appl Physiol 1974;36:381-4.